Regulations.gov document
Exhibit B - "FDA/CDER Response to Dr. Harvey" - [Actavis Elizabeth LLC (Axinn Veltrop &…
Supporting & Related Material · FDA-2009-N-0184 · posted Jun 8, 2009
Key facts
| Document ID | FDA-2009-N-0184-0011 |
|---|---|
| Title | Exhibit B - "FDA/CDER Response to Dr. Harvey" - [Actavis Elizabeth LLC (Axinn Veltrop & Harkrider LLP) - Comment] |
| Document type | Supporting & Related Material |
| Subtype | C-Comment (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2009-N-0184 |
| Posted | Jun 8, 2009 |
| Effective date | May 20, 2009 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: